As of January 1, 2025, ZULRESSO® (brexanolone) will no longer be commercially available in the U.S.

For questions, please reach out to Sage Central Support 844-4-SAGERX (844-472-4379) M-F, 8am - 6pm ET

This site is intended for US residents only.

Support starts here

Find patient support resources and programs for your Sage Therapeutics, Inc. medication.

ZULRESSO® (brexanolone) injection, CIV

See Full Prescribing Information including Boxed Warning for ZULRESSO